Associate Professor, China Pharmaceutical University.
Visiting Fellow, National Institute of Mental Health.
Tao Pang Ph.D.
National Institute of Mental Health,
National Institutes of Health,
Department of Health and Human Services.
Drug screening and drug development to seek novel small molecules or natural products for the treatment of neurodegener.
- Dr. Pang’s research focuses on the discovery of novel compounds by high-throughput screening or high-content screening in terms of molecular target-based assay or phenotypic assay, and drug development in order to provide therapeutics for the cerebral ischemic stroke and diabetes.
- He is also interested in the molecular mechanisms involved in brain inflammation, in order to prevent neuroinflammation and neuronal death, and promote brain functional recovery during cerebral ischemia.